Skip to main content


Fig. 3 | Journal of NeuroEngineering and Rehabilitation

Fig. 3

From: Shaping neuroplasticity by using powered exoskeletons in patients with stroke: a randomized clinical trial

Fig. 3

Primary outcome measures (10MWT 10 m walk test, RMI Rivermead Mobility Index, TUG timed up and go test) assessed at TPRE and TPOST in the two groups (EGT and OGT). Minimally Clinically Important Difference (MCID) and Minimal Detectable Change (MDC) are reported as well. * refer to post-hoc p-values of within-group analysis (significant whether p < 0.016), whereas # refer to p-values of between-group analysis for TPOST-TPRE difference (p < 0.05). Vertical error bars refer to SD

Back to article page